Novavax Climbs 15% on New CEO Appointment – Before You Invest, Here are 3 Things to Consider
Monday morning started with a bang for Novavax, a company specializing in developing and selling vaccines - as the name suggests. They’ve played a role in discovering and rolling out vaccines for the seasonal flu, COVID-19, Ebola, and many other illnesses. And today, the company issued a statement announcing the appointment of John Jacobs [...]